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Hyperinsulinemia Is Associated With Menstrual Irregularity and Altered Serum 
Androgens in Pima Indian Women 
Daniel J. Weiss, Marie Aline Charles, Andrea Dunaif, Donna E. Prior, Stephen Lillioja, William C. Knowler, 
and William H. Herman 
To determine whether hyperinsulinemia is associated with menstrual irregularity or hyperandrogenemia among Pima Indians, a 
population with a high prevalence of hyperinsulinemia, we retrospectively studied 20 hyperinsulinemic (higher insulin [HI]) and 
20 relatively nonhyperinsulinemic (lower insulin [LI]) nondiabetic Pima women 18 to 45 years of age. Reproductive histories 
were obtained by review of medical records. Stored serum samples were used for measurement of total testosterone, 
androstenedione, and dehydroepiandrosterone sulfate (DHEAS) levels. Fifty percent (nine of 18) of HI women had irregular 
menses, as compared with none of the LI women (0 of 19, P = .0004). HI women were significantly more obese than LI women. 
Serum testosterone and androstenedione levels were similar in HI and LI women (median testosterone, 1.13 v 1.13 nmol/L, 
P = .55; median androstenedione, 3.79 v 3.28 nmol/L, P = .90). Serum DHEAS was lower in HI than in LI women (median, 2.85 v 
4.55 pmol/L, P < .Ol). HI women with irregular menses had significantly higher testosterone levels than HI women with regular 
menses (median, 1.82 v 0.78, nmol/L,P = &I). Androstenedione and DHEAS levels were not different between these women. In 
conclusion, the association of obesity, hyperinsulinemia, irregular menstruation, and high testosterone concentration 
described in the polycystic ovarian syndrome (PCO) also occurs in Pima Indian women. Moreover, low concentrations of DHEAS 
are associated with hyperinsulinemia in these women. 
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T HE OBSERVATION that hyperinsulinemia increases ovarian production of androgens has been used to 
explain the association between insulin resistance, hyperin- 
sulinemia. hyperandrogenemia, and the polycystic ovarian 
syndrome (PCO).‘,2 Laboratory studies have demonstrated 
both increased production of androgens and increased 
responsiveness of ovarian androgen production to insulin in 
ovarian tissues isolated from women with PC0.3-5 Clinical 
studies have yielded conflicting results with respect to 
androgen production in response to in vivo insulin infu- 
sio+” or to stimulation of endogenous insulin secre- 
tiorl,1”-‘3 but some have suggested a direct effect of insulin 
on ovarian steroidogenesis. 
If hyperinsulinemia stimulates ovarian androgen produc- 
t ion, menstrual irregularities and hyperandrogenemia should 
occur frequently in hyperinsulinemic populations. How- 
ever, no published study has so far addressed this question. 
Pima Indians are known for a high prevalence of non- 
insulin-dependent diabetes,14 and nondiabetic Pima Indi- 
ans are hyperinsuhnemic compared with whites.‘” This 
study is a retrospective analysis of reproductive histories 
and of androgen concentrations from stored serum samples 
In ;I group of hyperinsulinemic and relatively nonhyperinsu- 
linemic nondiabetic Pima women of childbearing age. 
SUBJECTS AND METHODS 
L\‘ubjects 
IIata were obtained from volunteers participating in a longitudi- 
nal study of risk factors for the development of non-insulin- 
dependent diabetes, performed in the clinical research unit of the 
Wational Institutes of Health in Phoenix, AZ.rh Each subject stayed 
in the research unit for 8 to 15 days and underwent a physical 
examination including measurements of height and weight. On 
heparate days. oral and intravenous (IV) glucose tolerance tests 
,md hyperinsulinemic-euglycemic clamp studies were performed as 
prt,viously described.‘” 
The women included in this study were selected through their 
maulin concentrations, which were thought to be more relevant to 
tht- eventual ability to stimulate androgen production than the 
actual magnitude of insulin resistance. One hundred thirty-six 
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nondiabetic women aged 18 to 45 years were selected. They were 
ranked according to the insulin area under the oral glucose 
tolerance curve obtained from determinations at 0.30,60. 120, and 
180 minutes. The 20 women with the highest insulin area (range, 
301,140 to 685,884 pmol/L x 180 min) and the 20 women with the 
lowest insulin area (range, 42,390 to 134.730 pmol/L x 180 min) 
were chosen for chart review of reproductive history and androgen 
measurements in stored serum samples. 
Reproductive History 
Each subject’s medical record was reviewed, as was the detailed 
health questionnaire administered at the time of the clinical 
research unit study. The reviewer had no knowledge of the 
subject’s insulin area. Specific information was obtained concern- 
ing gravidity, parity. menarche, menstrual history and thyroid 
function. Oligomenorrhea was defined as either an interval of 2 or 
more months between menses or six or fewer menses per year. 
Amenorrhea was defined as an interval of 6 or more months 
between menses or two or fewer menses per year-. 
Biological Measurements 
Samples from the IV glucose tolerance tests. stored at -DC, 
were available for measurements of androgen levels. For each of 
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the 40 subjects, we used the samples of the S- and lO-minute 
aliquot post-IV glucose infusion. Samples for each individual were 
pooled and assayed for total testosterone, androstenedione, and 
dehydroepiandrosterone sulfate (DHEAS) according to published 
methods.” Sex hormone-binding globulin, dehydroepiandros- 
terone, and free testosterone levels were not determined because 
of insufficient sample availability. 
p=O.O06 
r---i 
To control for possible desication resulting from long-term 
sample storage, the protein content of each pooled sample was 
estimated by the Lowry method.‘* Analyses were performed using 
both the androgen concentrations and the ratio of androgen to 
protein concentrations. Since the results were similar, only data 
obtained using androgen concentrations are shown. 
Serum insulin concentrations were measured by radioimmunoas- 
say”” and plasma glucose concentrations by the glucose oxidase 
method. Rates of glucose uptake (M values) were calculated 
during the hyperinsulinemic-eugiycemic clamp at two different 
insulin infusion rates, low-dose and high-dose (0.24 and 2.4 
nmol/L/m2 body surface area per minute), and were adjusted for 
estimated metabolic body size and steady-state plasma glucose 
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Fig 1. Median serum androgen concentrations in LI and HI groups. 
Statistical Analysis 
Groups were compared with the Mann-Whitney test for continu- 
ous variables and Fisher’s Exact Test for categorical variables. In 
multivariate analyses, associations between menstrual patterns and 
androgen concentrations were tested by logistic regression. 
The proportion of women with irregular menses was 
markedly different between HI and LI women for whom 
information was available (50% v 0% respectively, 
P = .0004). Five of the HI subjects with irregular menses 
had oligomenorrhea, whereas four had histories of both 
oligomenorrhea and amenorrhea. 
RESULTS 
F’rom the chart review, menstrual histories were obtained 
for 37 of 40 subjects, gravidity and parity for 40, and age of 
menarche for 38. Thyroid functions were documented for 
27 women, all of which were within normal limits. 
Characterization of the study population by insulin con- 
centration is shown in Table 1. Women with higher insulin 
concentrations (HI) had significantly higher body mass 
indexes (BMIs) and fasting and 2-hour glucose concentra- 
tions and were significantly more insulin-resistant as shown 
by the lower M values than women with lower insulin 
concentrations (LI). Age and gravidity were not signifi- 
cantly different between the two groups. 
Because the BMI was higher in the HI group than in the 
LI group, a subgroup comparison was performed that was 
restricted to HI women with a BMI less than the median 
and LI women with a BMI greater than the median. Median 
BMIs of the HI and LI subgroups were 34.2 and 37.2 kg/m2, 
respectively (P = NS). Three of eight women with known 
menstrual histories in the HI subgroup had menstrual 
irregularities, as compared with none in the LI subgroup 
(Fisher’s Exact Test, P = .OS). 
There were no significant differences in serum testoster- 
one and androstenedione levels between HI and LI women 
(medians, 1.13 v 1.13 nmol/L, NS, and 3.79 v 3.26 nmol/L, 
NS, respectively); however, DHEAS was significantly lower 
in HI women (median, 4.55 v 2.85 pmol/L, P < .Ol; Fig I). 
Table 1. Characteristics of Women in the LI and HI Groups 
Median [Ql-Q31* 
LI HI P 
n 20 20 
Age (~1 24.7 [22.5-29.31 27.2 [23.2-32.01 > .05 
BMI (kg/m*] 28.6 [24.2-37.21 38.1 [34.2-43.01 .002 
Age at menarche (yr] 13 [12-131 12 [12-131 > .05 
Gravidity 2 [O-4] 2 [O-4] >.05 
% irregular menses 0 (O/19] 50 (9118) .0004 
Fasting glucose 
(mmol/L] 5.0 14.8~5.51 5.5 [5.2-&l] .003 
2-hour glucose (mmol/L) 7.1 [5.8-8.21 8.8 [7.2-IO.21 ,006 
Fasting insulin (pmol/L) 117 [102-1621 444 [360-5761 .OOOl 
P-hour insulin (pmol/L) 579 1417-7291 2,280 [2,184-2,937] .OOOl 
Insulin clamp 
Low-dose Mt 3.4 12.7-4.21 2.2 [2.0-2.51 ,001 
High-dose Mt 10.3 [8.7-IO.81 5.6 15.1-7.61 ,001 
*al-Q3 corresponds to the interquartile range. 
tM values are expressed in mg/min kg estimated metabolic body 
size. 
Among HI women, testosterone concentrations were 
higher in women with irregular menses than in those with 
normal menses (1.62 v 0.76, P = .0.5; Fig 2). In these 
women, a high testosterone concentration (defined as a 
concentration exceeding the median for the group) was 
associated with a 3.5-fold increased risk of having irregular 
menses as compared with the low-testosterone group 
(P = .03; Fig 3). In contrast, a high BMI (defined as a value 
exceeding the median for the group) was associated with 
only a 1.6-fold increased risk of irregular menses (P = .32). 
After adjusting for age, BMI, and M value (either from 
high- or low-insulin clamp) by multiple logistic regression, a 
high testosterone level remained associated with a higher 
probability of irregular menses (P = .04). Neither andro- 
stenedione nor DHEAS was associated with irregular 
menses in the HI group. 
DISCUSSION 
Pima Indians are notable for high insulin concentrations 
and a high degree of insulin resistance.‘” Among the 40 
Pima women of childbearing age selected, menstrual irregu- 
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Fig 2. Testosterone concentrations in LI and HI groups in women 
with (a) normal menses, (A) irregular menses, or (+) unknown status. 
(-) The median of each group. In the higher insulin group, (,.*.) and 
(----) indicate the medians for women with regular menses and 
irregular menses, respectiueiy. 
larnies were reported only in the HI women. The HI women 
were also more obese. Therefore, an association between 
hyperinsuiinemia, obesity, and menstrual irregularities, as 
described in women with PG0.r also occurs in Pima women. 
However, in this association the etiologic relationship 
remains unclear. Arguments supporting the hypothesis of 
hyperandrogenemia causing insulin resistance and hyperin- 
rulinemia have been based on studies in hyperandrogen- 
cmic women in whom insulin resistance decreased after 
reduction of androgenemia by treatment with oral contra- 
ceptives or spironolactone.~l,~~ However, these studies were 
constrained by imprecise measurements of insulin action 
and small sample size. Studies using more precise determi- 
nations of insulin sensitivity have shown that suppressing 
androgen levels with a gonadotropin-releasing hormone 
analog had no effect on insulin resistance in women with 
P(10.“3,24 Moreover, oophorectomy does not improve insu- 
lin sensitivity in women with PCO.zs 







Fig 3. Percentage of women with irregular menses in HI women as 
a function of testosterone concentrations (e or 3r the median for the 
group) and BMI (e or > the median for the group). 
linemia increases ovarian androgen production. Insulin and 
insulin-like growth factor I can bind to granulosa and theta 
cells in vitro, stimulating cell growth and androgen produc- 
tion.“,4 These effects may be synergistic with follicle- 
stimulating hormone or luteinizing hormone.“J Ovarian 
stroma isolated from women with PC0 show increased 
basal androgen release and increased responsiveness to 
insulin-stimulated androgen release compared with stroma 
isolated from normal women5 Insulin at high concentra- 
tions can bind to insulin-like growth factor I receptors and 
therefore still act on the ovary in the insulin-resistant state.? 
In vivo, prolonged insulin infusion at high concentrations 
performed in normal or hyperandrogenic wome@ has led 
to different results depending on the androgen considered. 
Androstenedione concentrations increased during insulin 
infusion,h,7 whereas testosterone concentrations did not 
changeh,” or decreased in hyperandrogenic women7 Insulin 
infusion at more physiologic concentrations showed either 
no response of testosterone~,~~l and androstenedioncl~ or an 
increase in androstenedione concentrations.” Stimulation 
of endogenous insulin by glucosei”-I3 or tolbutamide” did 
not lead to an increase in androstenedione or testosterone 
concentrations except in one study.‘: Using a different 
approach, Nestler et al’” have shown that decreasing insulin 
with diazoxide decreases the testosterone concentration, 
but has no effect on androstenedionc concentrations. The 
disparity in results among studies may arise in part from the 
fact that circulating androstenedione in women is of both 
ovarian and adrenal origin. Taken together, these studies 
suggest that prolonged insulin infusion can increase andro- 
stenedione concentrations, whereas decreasing insulin con- 
centrations can decrease testosterone concentrations. 
In the present study, testosterone and androstencdione 
concentrations were similar in HI and LI women; however, 
women in the HI group were also more obese. Therefore, 
since obesity is associated with lower concentrations of sex 
hormone-binding globulin,~7 it is possible that HI women 
had higher free-testosterone concentrations than LI women, 
despite comparable total testosterone concentrations. We 
were unable to measure sex hormone-binding globulin 
levels in the stored serum specimens, so we could not test 
this hypothesis directly. 
Among HI women, higher testosterone concentrations 
but not obesity were significantly associated with irregular 
menses. The mean testosterone concentration of HI women 
with irregular menses was similar to the mean reported 
previously in obese PC0 womenZx Thus, the high preva- 
lence of irregular menses in obese HI Pima women may be 
related to hypertestosteronemia secondary to stimulation 
of ovarian androgen production by insulin. 
Alternatively, obesity per se may have produced insulin 
resistance, alterations in androgen metabolism, and men- 
strual irregularities.24-32 Arguing against this is the fact that 
among subgroups of similar BMl, menstrual irregularities 
tended to be more frequent in Hl than in LI women. In 
addition, in the HI group, oniy women with menstrual 
irregularities had elevated testosterone levels. Not all obese 
women had menstrual irregularities and high testosterone 
concentrations. This suggests that there are additional 
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susceptibility factors, possibly genetically determined,33,34 
for the development of reproductive disturbances in obese 
HI women. 
The significantly lower DHEAS concentration in HI 
versus LI women is consistent with most of the results in the 
literature showing a decrease of DHEAS after either 
infusion of exogenous insulins-*” or stimulation of endog- 
enous insulin se~retion.lo,l* The mechanism of the relation 
between DHEAS and insulin ~ncentrations is not yet 
completely understood, but recent data from in vivo studies 
In summary, menstrual irregularities occur frequently 
among obese HI Pima women and are associated with 
higher concentrations of total testosterone. Hyperinsu- 
linemia is also associated with lower concentrations of 
DHEAS. 
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